Stock Price
700.90
Daily Change
45.10 6.88%
Monthly
8.75%
Yearly
48.21%
Q2 Forecast
636.32

Compugen reported $102.73M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Arca Biopharma USD 469M 17.79M Dec/2025
aTyr Pharma USD -24.12M 104.35M Dec/2025
Bio Path USD -8M 846K Sep/2025
Brainstorm Cell Therapeutics USD -9.98M 2.29M Dec/2025
Cara Therapeutics USD 27.87M 5.06M Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
Immunic USD 10.5M 23.41M Sep/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
RedHill Biopharma USD -4.41M 271K Jun/2025
TherapeuticsMD USD 27.67M 990K Jun/2024